May 21, 2012
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved a labeling update. …
May 16, 2012
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Alex Kelly, senior vice president, investor relations, is schedul. …
May 10, 2012
Bowles Richard S Iii sold 27,377 shares of Merck & Co. Inc stock, or $1,054,014 worth, as noted in an SEC Filing today.
As reported in the filing, the transactions …
September 19, 2011
Deluca Richard R.'s title was listed as "EVP&Pres, Merck Animal Health" at Merck & Co. Inc. within the filing.
August 15, 2011
Kenneth Frazier purchased 32,000 shares of Merck & Co. Inc. stock, or $1,016,838 worth, as noted in an SEC Filing today. After the transaction, Kenneth Frazier's stake was reported as 192,520 shares o …
August 15, 2011
Peter Kellogg purchased 15,800 shares of Merck & Co. Inc. stock, or $502,366 worth, as noted in an SEC Filing today. After the transaction, Peter Kellogg's stake was reported as 53,999 shares of Merck …
July 1, 2011
Thomas Glocer listed their title as "Director" at Merck & Co. Inc. within the filing.
July 1, 2011
Steven Goldstone listed their title as "Director" at Merck & Co. Inc. within the filing.
July 1, 2011
Willam Kelley listed their title as "Director" at Merck & Co. Inc. within the filing.
July 1, 2011
Harrison William B Jr listed their title as "Director" at Merck & Co. Inc. within the filing.
July 1, 2011
Rochelle Lazarus listed their title as "Director" at Merck & Co. Inc. within the filing.
July 1, 2011
Anne Tatlock listed their title as "Director" at Merck & Co. Inc. within the filing.
July 1, 2011
Wendell Weeks listed their title as "Director" at Merck & Co. Inc. within the filing.
July 1, 2011
Peter Wendell listed their title as "Director" at Merck & Co. Inc. within the filing.
June 29, 2011
Merck & Co. Inc. filed their Annual Report of Employee Stock Purchase on June 29, 2011 with the U.S. Securities and Exchange Commission.
June 28, 2011
Merck & Co. Inc. filed their Annual Report of Employee Stock Purchase on June 28, 2011 with the U.S. Securities and Exchange Commission.
June 28, 2011
Merck & Co. Inc. filed their Annual Report of Employee Stock Purchase on June 28, 2011 with the U.S. Securities and Exchange Commission.
June 28, 2011
Merck & Co. Inc. filed their Annual Report of Employee Stock Purchase on June 28, 2011 with the U.S. Securities and Exchange Commission.
June 28, 2011
Merck & Co. Inc. filed their Annual Report of Employee Stock Purchase on June 28, 2011 with the U.S. Securities and Exchange Commission.
May 31, 2011
Kidder C Robert listed their title as "Director" at Merck & Co. Inc. within the filing.
May 31, 2011
Thompson Craig B. listed their title as "Director" at Merck & Co. Inc. within the filing.
May 31, 2011
Thomas Cech listed their title as "Director" at Merck & Co. Inc. within the filing.
May 31, 2011
Anne Tatlock's title was listed as "Director" at Merck & Co. Inc. within the filing.
May 31, 2011
Willam Kelley's title was listed as "Director" at Merck & Co. Inc. within the filing.
May 31, 2011
Wendell Weeks's title was listed as "Director" at Merck & Co. Inc. within the filing.
